Novel targets for HIV-1: Tat-TAR interactions
Novel targets for HIV-1: Tat-TAR interactions
批准号:
6405888
负责人:
Robert Rando
金额:
$14.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-10 至 2002-03-31
中文摘要
描述(由申请人提供):人类免疫缺陷病毒
英文摘要
DESCRIPTION (Provided by the applicant): The human immunodeficiency virus
type-i (HIV-i) is a complex retrovirus that encodes six regulatory proteins,
including Tat. The Tat protein is a potent transcriptional activator of the
HIV-1 long terminal repeat promoter element. A regulatory element between +1
and +60 in the HIV-1`long terminal repeat which is capable of forming a stable
stem-loop structure, designated TAR, is critical for Tat function. In the
absence of Tat, RNA polymerase II (pol II) terminates transcription
prematurely. Tat-TAR interactions help convert pol II interactions with the RNA
template into efficiently produced full-length viral transcripts. We have
recently demonstrated that combinatorial libraries composed of tripeptides
contained molecules that not only bound to TAR but also inhibited Tat
interaction with Tar and subsequent LTR directed transcription was reduced in
cell culture. The goal of the proposed research is the discovery of low
molecular weight non-peptide compounds that inhibit HIV replication by binding
to the TAR RNA element. The success of this research would open the door to new
opportunities in the discovery of drugs which bind to discrete RNA structures
with possible applications for diseases such as cancer and aids.
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTIVE ANTIHIV GUANOSINE/THYMIDINE OLIGONUCLEOTIDES
-
批准号:2074045
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1995
-
负责人:Robert Rando
-
依托单位:
ANTI-HCMV ACTIVITY OF TRIPLE HELIX-FORMING OLIGOS
-
批准号:3489795
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1993
-
负责人:Robert Rando
-
依托单位:
SMALL INSTRUMENTATION PROGRAM
-
批准号:3523272
-
项目类别:
-
资助金额:$0.74万
-
财政年份:1988
-
负责人:Robert Rando
-
依托单位:
海外基金